# OnCo record nikang-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/nikang-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "nikang-therapeutics" ;
  schema:name "NiKang Therapeutics"@en ;
  schema:alternateName "NiKang Therapeutics, Inc."@en, "Nikang Therapeutics"@en ;
  schema:description "A US company making pills that block or break down cancer-driving proteins. Its drugs are in early trials for kidney cancer, liver cancer, hormone-receptor-positive breast cancer and other solid tumours."@en ;
  schema:url <https://onco.cc/companies/nikang-therapeutics/>, <https://www.nikangtx.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.nikangtx.com/>, <https://www.nikangtx.com/science-and-pipeline/>, <https://www.nikangtx.com/about-us/>, <https://www.racap.com/portfolio/nikang-therapeutics> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/clear-cell-rcc/>, <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/endometrial/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/protac-degrader/> ;
  onco:targets <https://onco.cc/targets/hif2a/>, <https://onco.cc/targets/cdk2/> ;
  onco:drugs <https://onco.cc/drugs/nkt2152/>, <https://onco.cc/drugs/nkt3964/>, <https://onco.cc/drugs/nkt5097/> .